Insiders · Profile

MULLEN JAMES C

CEO at Editas Medicine · Director at Insulet · Director at Revvity · and 1 more. Filing since 16 Nov 2006. CIK 0001226288

EDIT Editas Medicine, Inc. CEO · 4 trades PODD Insulet Corporation Director · 1 trade RVTY Revvity Director · 5 trades BIIB Biogen CEO & President · 10 trades

Company

Date

Role

Action

Shares

Amount

Of holding

EDIT Editas Medicine, Inc.

3 Jan 2022

CEO

Sold, plan not stated

18,252

$491.98K

19.4%

EDIT Editas Medicine, Inc.

18 Oct 2021

CEO

Sold, plan not stated

13,805

$525.03K

19.3%

EDIT Editas Medicine, Inc.

2 Mar 2021

CEO

Bought

25,000

$1.16M

250%

EDIT Editas Medicine, Inc.

18 May 2018

Director

Bought

10,000

$380.25K

opened

PODD Insulet Corporation

13 Nov 2017

Director

Bought

2,500

$168.63K

80.7%

14 Nov 2014

Director

Sold, plan not stated

8,892

$388.84K

16.3%

7 Feb 2014

Director

Sold, plan not stated

12,951

$566.33K

23.1%

30 Apr 2013

Director

Sold, plan not stated

6,440

$195.20K

13.9%

21 Feb 2012

Director

Sold, plan not stated

5,865

$157.48K

13.9%

4 Nov 2010

Director

Sold, plan not stated

10,000

$240.00K

23.4%

22 Mar 2010

CEO & President

Sold, plan not stated

106,279

$6.37M

44.8%

19 Mar 2010

CEO & President

Sold, plan not stated

334,221

$20.04M

71.8%

16 Dec 2009

CEO & President

Sold, plan not stated

147,037

$7.38M

56.7%

15 Apr 2008

CEO & President

Sold, plan not stated

12,800

$831.36K

8.6%

14 Apr 2008

CEO & President

Sold, plan not stated

200

$12.99K

0.1%

11 Apr 2008

CEO & President

Sold, plan not stated

745,750

$48.29M

84.5%

27 Nov 2006

CEO & President

Sold, plan not stated

12,500

$637.34K

11.7%

20 Nov 2006

CEO & President

Sold, plan not stated

159,000

$8.14M

62.8%

17 Nov 2006

CEO & President

Sold, plan not stated

70,123

$3.50M

42.7%

16 Nov 2006

CEO & President

Sold, plan not stated

229,877

$11.48M

70.9%

20 decisions on file.